Company intelligence / Profile preview

NAMBAWAN Biotech

Port Moresby, National Capital District, Papua New Guinea

Ownership: Private
Development stage: Other

Overview

Nambawan Biotech is a specialized medical diagnostic and laboratory services provider based in Port Moresby, Papua New Guinea. Established to enhance regional healthcare infrastructure, the company provides advanced molecular testing, pathology, and clinical laboratory services. It played a critical role in the national response to the COVID-19 pandemic by providing high-capacity PCR testing and diagnostic support. Beyond infectious diseases, the firm focuses on delivering high-quality medical screenings and diagnostic solutions to both public and private healthcare sectors in PNG.

Therapeutic areas: Infectious Diseases
Industry: Molecular Diagnostics

Partnerships

National Department of Health (PNG)

Beyond the preview

Go deeper on NAMBAWAN Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NAMBAWAN Biotech.

Explore the full profile